Ankylosing Spondylitis and Vaccinations: Essential Guidelines

Ankylosing Spondylitis and Vaccinations: Essential Guidelines
21 Oct, 2025
by Trevor Ockley | Oct, 21 2025 | Health | 2 Comments

Living with Ankylosing Spondylitis is a daily balancing act between pain, stiffness, and the need to stay active. Add vaccinations into the mix, and the equation can feel even more confusing. This guide walks you through what you need to know so you can protect yourself without compromising your treatment plan.

What Is Ankylosing Spondylitis?

Ankylosing Spondylitis (AS) is a chronic inflammatory disease that primarily attacks the spine and sacroiliac joints, eventually leading to fusion of the vertebrae. It belongs to the broader family of spondyloarthropathies and shows a strong genetic link to HLA‑B27. HLA‑B27 is a protein on the surface of white blood cells that, when present, increases the odds of developing AS by up to 80% in certain populations.

Typical symptoms include lower back pain that improves with movement, morning stiffness lasting more than an hour, and reduced chest expansion. Over time, the inflammation can cause new bone formation, making the spine rigid. Early diagnosis and a combination of medication, physiotherapy, and lifestyle changes can slow progression.

Vaccinations 101: Types and How They Work

Vaccinations are medical preparations that train the immune system to recognize and fight specific pathogens without causing disease. The main categories are:

  • Live attenuated vaccines: contain a weakened form of the germ (e.g., measles, varicella). They provoke a strong, long‑lasting response but can be risky for people with weakened immunity.
  • Inactivated vaccines: use killed germs or fragments (e.g., flu shot, hepatitis B). Safer for immunocompromised patients but often require boosters.
  • Subunit, recombinant, and mRNA vaccines: deliver only parts of the pathogen (e.g., COVID‑19 mRNA vaccines). They are highly specific and have excellent safety profiles.

Understanding these categories is crucial because many AS patients are on immunosuppressive medication, which changes how they should approach each vaccine type.

Why Vaccination Matters for People with Ankylosing Spondylitis

Living with AS often means taking drugs that dampen the immune system, such as Biologic therapy. Biologics target specific inflammatory pathways, notably tumor necrosis factor (TNF) and interleukin‑17 (IL‑17), and are highly effective at controlling disease activity. While these medications improve quality of life, they also reduce the body’s ability to fight infections.

Respiratory infections, especially influenza and pneumococcal disease, are more common and can trigger flares of AS. A severe infection may also force a temporary halt of biologic treatment, risking a rebound of inflammation. Therefore, staying up‑to‑date with vaccines is a proactive way to safeguard both general health and the stability of your AS regimen.

Split scene of live vs inactivated vaccines with patient on biologic medication.

Safety Concerns: Live vs. Inactivated Vaccines

The biggest safety question revolves around whether live vaccines are safe for patients on immunosuppressive drugs. Current guidelines suggest:

  • Live vaccines (e.g., varicella, measles‑mumps‑rubella, yellow fever) should generally be avoided while on high‑dose biologics or systemic steroids. If a live vaccine is essential, a temporary medication pause-usually 2‑4 weeks before and after the shot-may be recommended.
  • Inactivated vaccines (e.g., flu, COVID‑19, pneumococcal) are considered safe and are strongly encouraged. They can be administered without altering most AS medications.

Research published in the Arthritis & Rheumatology journal (2023) reviewed over 2,000 AS patients on TNF inhibitors and found no increase in serious adverse events after receiving inactivated vaccines. However, a small uptick in mild local reactions (redness, soreness) was noted, which is typical for any vaccine.

Vaccines Most Relevant to Ankylosing Spondylitis Patients

Below is a quick rundown of the vaccines you should discuss with your rheumatologist:

  1. Seasonal Influenza (Flu) Vaccine: Year‑ly inactivated shot. Reduces the risk of flu‑related arthritis flares.
  2. COVID‑19 Vaccine: mRNA or viral‑vector formulations are both safe. Booster doses are recommended according to national guidelines.
  3. Pneumococcal Vaccine: Two‑dose series (PCV13 followed by PPSV23) protects against bacterial pneumonia, a serious threat for immunocompromised adults.
  4. Hepatitis B Vaccine: Important for anyone receiving long‑term immunosuppressants, as liver infections can complicate medication metabolism.
  5. Shingles (Herpes Zoster) Vaccine: Recombinant subunit (Shingrix) is preferred over the live attenuated version for patients on biologics.
  6. Human Papillomavirus (HPV) Vaccine: Recommended up to age 45; protects against virus‑related cancers, which can be more aggressive in immunosuppressed individuals.

Live vaccines such as the traditional varicella or yellow fever shots are generally postponed or avoided unless travel or specific exposure makes them unavoidable.

Timing Vaccinations Around Your Medication

Coordinating vaccine timing with your AS treatment can maximise protection and minimise risks. Here’s a practical cheat‑sheet:

  • NSAIDs (e.g., ibuprofen): No need to alter timing; they don’t affect immune response significantly.
  • Conventional DMARDs (e.g., methotrexate): Aim to give inactivated vaccines at the start of a dosing cycle, when drug levels are at their lowest.
  • TNF inhibitors (e.g., etanercept, adalimumab): Inactivated vaccines can be given at any point. For live vaccines, stop the drug 2-4 weeks before the shot and resume at least 2 weeks after, if disease activity permits.
  • IL‑17 inhibitors (e.g., secukinumab): Same guidance as TNF blockers.
  • Corticosteroids (≥10 mg prednisone daily): Consider reducing dose before live vaccines if possible; otherwise prefer inactivated options.

Always consult your rheumatologist before making any changes; abrupt medication stops can trigger disease flare‑ups.

Clipboard with checked vaccination steps surrounded by pills, vaccine vial, and doctor.

Live vs Inactivated Vaccines - Quick Comparison

Live vs Inactivated Vaccines for Ankylosing Spondylitis Patients
Aspect Live Vaccine Inactivated Vaccine
Immunity Strength Strong, long‑lasting Good, often requires boosters
Safety with Immunosuppression Potentially unsafe; may need medication pause Generally safe; can be given anytime
Typical Examples Varicella, MMR, Yellow Fever Flu (inactivated), COVID‑19 mRNA, Pneumococcal
Side‑effect Profile Mild viral symptoms; rare severe reactions Local soreness, low‑grade fever; rare allergic reactions

Practical Checklist Before Your Next Vaccine

  • Make a list of all current AS medications (dose, frequency).
  • Ask your rheumatologist if any medication adjustments are needed.
  • Confirm whether the vaccine is live or inactivated.
  • Schedule the appointment at a time when disease activity is stable.
  • Bring a written record of past vaccinations and any allergic reactions.
  • After the shot, monitor for unusual joint pain or fever lasting more than 48 hours and report to your doctor.

Following this checklist can help you avoid unnecessary delays and keep both your immune system and AS under control.

Frequently Asked Questions

Can I get the flu shot while on a TNF inhibitor?

Yes. The flu vaccine is inactivated and considered safe for patients taking TNF inhibitors. No medication pause is needed.

Should I avoid the shingles vaccine because I’m on biologics?

Choose the recombinant subunit vaccine (Shingrix). It’s non‑live and safe for biologic users. The older live shingles vaccine should be avoided.

What if I need a travel vaccine that’s live, like yellow fever?

Discuss a temporary hold of your biologic with your rheumatologist-usually 2-4 weeks before and after the shot. If stopping isn’t possible, weigh the travel risk versus disease flare risk.

Do vaccines trigger an AS flare?

Mild, short‑lived joint discomfort can occur, but large studies show no increase in serious flares after inactivated vaccines. If you notice worsening symptoms, contact your doctor.

How often should I get the pneumococcal vaccine?

Adults on immunosuppressive therapy get a 13‑valent PCV13 dose first, followed by a PPSV23 dose at least 8 weeks later. A booster of PPSV23 is recommended every 5 years.

Staying on top of your vaccine schedule doesn’t have to be a headache. By understanding the types of vaccines, coordinating with your medication plan, and keeping an open line with your rheumatologist, you can protect yourself against preventable illnesses and keep your ankylosing spondylitis as stable as possible. Remember, the goal is to stay healthy enough to enjoy life-and that starts with informed choices about vaccination.

Write a comment

Your email address will not be published. Required fields are marked*